Dysregulated growth hormone (GH) hypersecretion is usually caused by a GH-secreting
pituitary adenoma and leads to acromegaly—a disorder of disproportionate skeletal, tissue …

The CLINICAL consequences of advanced acromegaly are disfigurement, disability, and
shortened life expectancy due to respiratory, metabolic, cardiovascular, and malignant …

Acromegaly is an insidious disorder caused by a pituitary GH-secreting adenoma resulting
in high circulating levels of GH and IGF-I (1). Unfortunately, no single therapy is …

Acromegaly is caused by excess growth hormone (GH) secretion emanating from a
somatotroph adenoma. High GH and Insulin-like growth factor-1 (IGF-1) levels lead to acral …

Acromegaly is characterized by increased release of growth hormone and, consequently,
insulin-like growth factor I (IGF1), most often by a pituitary adenoma. Prolonged exposure to …

Acromegaly is a rare disease characterized by excess secretion of growth hormone (GH)
and increased circulating insulin-like growth factor 1 (IGF-1) concentrations. The disease is …

abstract Acromegaly, an indolent disorder of growth hormone (GH) hypersecretion is most
typically caused by a somatotroph cell adenoma and may be treated by several modalities …

Acromegaly is a chronic disease characterized by the presence of a pituitary growth
hormone (GH)-producing tumour, excessive secretion of growth hormone, raised levels of …

Acromegaly is usually caused by a GH-secreting pituitary adenoma. Somatic growth and
metabolic dysfunction occur subsequent to unrestrained GH secretion and elevated insulin …

Acromegaly is a rare disease caused by growth hormone hypersecretion, mostly from a
pituitary adenoma, driving insulin-like growth factor 1 overproduction. Manifestations include …